HNN3.0
Register
Register
Register

Nexyra Advanced Research

Start-up

www.nexyraresearch.com/Madrid, Spain
6 profile visits

About

Nexyra Advanced Research develops multi-omics intelligence solutions that integrate molecular and clinical data using systems biology and artificial intelligence, focusing on biomarker identification, therapeutic target prioritization, and the development of predictive and prognostic models in complex biomedical contexts.

Its technology enables the integrated analysis and interpretation of large volumes of omics data, generating actionable insights for decision-making in translational research, pharmaceutical development, and precision medicine.

Nexyra's solutions primarily target the biotechnology, pharmaceutical, clinical research, and precision medicine markets, with a particular focus on complex diseases and environments of high biological heterogeneity.

Representatives

CEO & Co-Founder

Nexyra Advanced Research

Resources

Marketplace (1)

  • Project cooperation

    Multi-omics (AI) Biomarker & Predictive Model Co-Development for Precision Medicine

    Seeking clinical/biotech partners to co-develop biomarkers and predictive models by integrating multi-omics and clinical data (AI).

    • Consortium/Coordinator seeks Partners
    • Partner seeks Consortium/Coordinator
    • DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-15: Scaling up innovation in cardiovascular health
    • DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-04: Development of novel vaccines for viral pathogens with epidemic potential
    • DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-03: Advancing research on the prevention, diagnosis, and management of post-infection long-term conditions
    • DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-05: Pilot actions for follow-on funding: Leveraging EU-funded collaborative research in regenerative medicine
    • DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-07: Establishing a European network of Centres of Excellence (CoEs) for Advanced Therapies Medicinal Products (ATMPs)
    • DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-06: Support to European Research Area (ERA) action on accelerating New Approach Methodologies (NAMs) to advance biomedical research and testing of medicinal products and medical devices
    • DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-09: Multisectoral approach to tackle chronic non-communicable diseases: implementation research maximising collaboration and coordination with sectors and in settings beyond the healthcare system (GACD)
    Author

    CEO & Co-Founder at Nexyra Advanced Research

    Madrid, Spain